CCNE2

CCNE2

Target · Cell cycle cyclin

CCNE2 Cyclin E2 · G1/S-specific cyclin-E2

CCNE2 (cyclin E2, CYCE2) is a member of the cyclin family that acts as a regulatory subunit of CDK2 and helps control the cell cycle at late G1 and early S phase. It belongs to the cyclin E subfamily alongside cyclin E1. Browse Assay Genie's current range of CCNE2 research reagents below, or read on for the biology behind the target.

Nuclear proteinCDK2 regulatory subunitPeaks at G1-S phase
404 aa
Protein length
~47 kDa
Molecular weight
8q22.1
Gene locus
Cyclin E
Cyclin subfamily
Target information

What is CCNE2 (cyclin E2)?

CCNE2 is essential for the control of the cell cycle at the late G1 and early S phase. It forms a complex with CDK2 and functions as the regulatory subunit of that kinase. Cyclins in general act as regulators of CDK kinases, and CCNE2 has been shown to interact specifically with members of the CIP/KIP family of CDK inhibitors. Through these interactions it plays a role in the G1/S transition.

The CCNE2 gene encodes G1/S-specific cyclin-E2, a nuclear protein of the highly conserved cyclin family. Members of this family are characterised by a marked periodicity in protein abundance through the cell cycle. Different cyclins show distinct expression and degradation patterns, which helps to coordinate the timing of each mitotic event. Expression of CCNE2 peaks at the G1-S phase, so any CCNE2 protein measurement is best interpreted with cell cycle position in mind.

CCNE2 shows a pattern of tissue specificity distinct from that of cyclin E1 (CCNE1), the other member of the cyclin E subfamily. A significantly increased expression level of the CCNE2 gene has been observed in tumour-derived cells, which has made it a point of interest in studies of proliferation control. The gene is also known by the alias CYCE2, and the mouse ortholog is Ccne2.

Cell cycle regulation

CCNE2 is essential for control of the cell cycle at late G1 and early S phase, making it central to studies of G1/S progression.

CDK2 signalling

CCNE2 forms a complex with CDK2 as its regulatory subunit, so it is relevant to work on cyclin-dependent kinase activity.

CDK inhibitor interactions

CCNE2 interacts specifically with the CIP/KIP family of CDK inhibitors, supporting research into how G1/S transition is restrained.

Tumour cell biology

Expression of CCNE2 is significantly increased in tumour-derived cells, motivating its study in proliferation and cancer models.

Background

CCNE2 frequently asked questions

What does CCNE2 do?

CCNE2 is a cyclin that is essential for control of the cell cycle at late G1 and early S phase. It acts as a regulatory subunit of CDK2 and interacts with CIP/KIP family CDK inhibitors, playing a role in the G1/S transition.

What other names does CCNE2 go by?

CCNE2 is the HGNC symbol for cyclin E2, and CYCE2 is a listed alias. The UniProt protein name is G1/S-specific cyclin-E2. It is a member of the cyclin E subfamily, together with cyclin E1 (CCNE1).

How is CCNE2 linked to cancer and conserved across species?

NCBI Gene reports significantly increased CCNE2 expression in tumour-derived cells. The gene belongs to the highly conserved cyclin family, and the mouse ortholog is Ccne2. Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Cyclin E1 and other cell cycle regulators with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt O96020; product specifications from Assay Genie datasheets.

CCNE2 Product listing